Dermatofibrosarcoma protuberans: the diagnosis of high-grade fibrosarcomatous transformation.


Journal

Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 19 07 2020
accepted: 16 09 2020
revised: 15 09 2020
pubmed: 2 10 2020
medline: 25 6 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Dermatofibrosarcoma protuberans (DFSP) is an intermediate-grade tumour which may undergo fibrosarcomatous transformation to a high-grade sarcoma (DFSP-FST). DFSP-FST requires wide local resection, and therefore, pre-operative identification is important. The aims of this study are to see if DFSP and DFSP-FST can be differentiated based on MRI appearances, and to determine the ability of ultrasound-guided core needle biopsy (US-CNB) to identify DFSP-FST. Retrospective review of patients with a histological diagnosis of DFSP with/without transformation to DFSP-FST. Patient age, gender, lesion location and maximal size were recorded, as were several MRI features. MRI studies were reviewed independently by 2 musculoskeletal radiologists and the assessed features were then compared with final surgical resection histology. Histological results of US-CNB were also compared with final surgical pathology. A total of 42 patients were included, 26 males and 16 females with a mean age of 41.3 years (range 3-78 years). The upper limb was involved in 12 cases, the lower limb in 17 and the trunk in 13. Final surgical histological diagnosis was DFSP in 21 (50%) cases and DFSP-FST in 21 (50%) cases. Mean tumour dimension for DFSP was 32 mm and DFSP-FST 68 mm (p < 0.001). MRI features indicative of DFSP-FST included multi-lobular morphology (p = 0.03), T2W hypointensity compared with fat (p = 0.03), internal flow voids (p = 0.03) and peri-tumoral oedema (p < 0.001). Only 3 cases of DFSP-FST were correctly diagnosed on US-CNB. Various MRI findings can suggest a diagnosis of DFSP-FST, but US-CNB is unreliable at identifying high-grade fibrosarcomatous transformation.

Identifiants

pubmed: 33001221
doi: 10.1007/s00256-020-03617-3
pii: 10.1007/s00256-020-03617-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-799

Références

Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013;30:13–28.
doi: 10.1053/j.semdp.2012.01.002
Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma protuberans. Dermatol Clin 2019;37:483–488.
Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129–134.
Weinstein JM, Drolet BA, Esterly NB, Rogers M, Bauer BS, Wagner AM, et al. Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol. 2003;139:207–11.
doi: 10.1001/archderm.139.2.207
Kornik RI, Muchard LK, Teng JM. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment. Pediatr Dermatol. 2012;29:707–13.
doi: 10.1111/j.1525-1470.2012.01767.x
Liang CA, Jambusaria-Pahlajani A, Karia PS, Elenitsas R, Zhang PD, Schmults CD. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. J Am Acad Dermatol. 2014;71:781–6.
doi: 10.1016/j.jaad.2014.03.018
Voth H, Landsberg J, Hinz T, Wenzel J, Bieber T, Reinhard G, et al. Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol. 2011;25:1385–91.
doi: 10.1111/j.1468-3083.2011.04141.x
Al Barwani AS, Taif S, Al Mazrouai RA, Al Muzahmi KS, Alrawi A. Dermatofibrosarcoma protuberans: insights into a rare soft tissue tumor. J Clin Imaging Sci. 2016;6:16.
doi: 10.4103/2156-7514.181492
Kransdorf MJ, Meis-Kindblom JM. Dermatofibrosarcoma protuberans: radiologic appearance. AJR Am J Roentgenol. 1994;163:391–4.
doi: 10.2214/ajr.163.2.8037038
Torreggiani WC, Al-Ismail K, Munk PL, Nicolaou S, O’Connell JX, Knowling MA. Dermatofibrosarcoma protuberans: MR imaging features. AJR Am J Roentgenol. 2002;178:989–93.
doi: 10.2214/ajr.178.4.1780989
Zhang L, Liu Q, Cao Y, Zhong J, Zhang W. Dermatofibrosarcoma protuberans: computed tomography and magnetic resonance imaging findings. Medicine (Baltimore). 2015;94:e1001.
doi: 10.1097/MD.0000000000001001
Bergin P, Rezaei S, Lau Q, Coucher J. Dermatofibrosarcoma protuberans, magnetic resonance imaging and pathological correlation. Australas Radiol. 2007;51 Spec No.:B64–66.
Thornton SL, Reid J, Papay FA, Vidimos AT. Childhood dermatofibrosarcoma protuberans: role of preoperative imaging. J Am Acad Dermatol. 2005;53:76–83.
doi: 10.1016/j.jaad.2004.11.071
Serra-Guillén C, Sanmartín O, Llombart B, Nagore E, Deltoro C, Martín I, et al. Correlation between preoperative magnetic resonance imaging and surgical margins with modified Mohs for dermatofibrosarcoma protuberans. Dermatol Surg. 2011;37:1638–45.
doi: 10.1111/j.1524-4725.2011.02077.x
Hakozaki M, Yamada H, Hasegawa O, Watanabe K, Konno S. Radiologic-pathologic correlations of fibrosarcomatous dermatofibrosarcoma protuberans with various histological features on enhanced MRI and PET/MRI. Clin Nucl Med 2016;41:241–243.
Mentzel T, Schärer L, Kazakov DV, Michal M. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am J Dermatopathol. 2007;29:443–8.
doi: 10.1097/DAD.0b013e318145413c
Jha P, Moosavi C, Fanburg-Smith JC. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M Enzinger Ann Diagn Pathol 2007;11:81–88.
Goldblum J, Weiss S, Folpe A. Enzinger and Weiss’s soft tissue tumours. 7th ed. Elsevier; 2019.
Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.
doi: 10.1002/ijc.2910330108
Colletti SM, Tranesh GA, Whetsell CR, Chambers LN, Nassar A. High diagnostic accuracy of core needle biopsy of soft tissue tumors: an institutional experience. Diagn Cytopathol. 2016;44:291–8.
doi: 10.1002/dc.23440
Rohela H, Lee C, Yoo HJ, Kim H-S, Kim Y, Cho HS, et al. Comparison of the diagnostic performances of core needle biopsy in myxoid versus non-myxoid tumors. Eur J Surg Oncol. 2019;45:1293–8.
doi: 10.1016/j.ejso.2019.05.001
Tan A, Rajakulasingam R, Saifuddin A. Diagnostic concordance between ultrasound-guided core needle biopsy and surgical resection specimens for histological grading of extremity and trunk soft tissue sarcoma. Skeletal Radiol. 2020
Chhabra A, Ashikyan O, Slepicka C, Dettori N, Hwang H, Callan A, et al. Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading. Eur Radiol. 2019;29:4485–94.
doi: 10.1007/s00330-018-5845-9

Auteurs

Paul Choong (P)

Spinal Cord Injuries Unit, Royal National Orthopaedic Hospital, Stanmore, UK.

Daniel Lindsay (D)

Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.

Michael Khoo (M)

Department of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK. michael.khoo@nhs.net.

Asif Saifuddin (A)

Department of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH